Authors:
Sebire NJ. Snijders RJM. Hughes K. Sepulveda W. Nicolaides KH.
Institution:
Harris Birthright Research Center, Fetal Medicine, King's College Hosp. Medical School, Denmark Hill,London SE5 8RX; United Kingdom.
Title:
Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Source:
British Journal of Obstetrics and Gynaecology. Vol 103(10) (pp99-1003), 1996.
Abstract:
Objectives:
To determine the prevalence of increased fetal nuchal translucency thickness in twin pregnancies and to evaluate screening for trisomy 21 by a combination of translucency thickness and maternal age.
Design:
Prospective screening study at 10 to 14 weeks of gestation.
Setting:
Fetal Medicine Centre. Population 22,518 self-selected pregnant women at 10 to 14 weeks of gestation, including 21,477 singleton and 448 twin pregnancies with live fetuses.
Methods:
Fetal nuchal translucency thickness was measured by ultrasound examination at 10-14 weeks. Sensitivity and false positive rates of screening for trisomy 21 by a combination of fetal nuchal translucency thickness and maternal age were calculated.
Settings, Design and Main Outcome Measures:
Prevalence of increased nuchal translucency thickness and detection of trisomy 21.
Results:
In the 448 twin pregnancies the nuchal translucency thickness was above the 95th centile of the normal range (for crown-rump length in singletons) in 65/896 fetuses (7.3%), including 7/8 (88%) with trisomy 21. Increased translucency was also present in four fetuses with other chromosomal abnormalities. In the chromosomally normal twin pregnancies the prevalence of increased nuchal translucency was higher in fetuses from monochorionic (8.4%; 16/190) than in those with dichorionic pregnancies (5.4%; 37/688). The minimum estimated risk for trisomy 21, based on maternal age and fetal nuchal translucency thickness, was 1 in 300 in 19.5% (175/896) of the twins including all eight of those with trisomy 21.
Conclusions:
In twin pregnancies the sensitivity of fetal nuchal translucency thickness in screening for trisomy 21 is similar to that in singleton pregnancies, but the specificity is lower because translucency is also increased in chromosomally normal monochorionic twin pregnancies.
Please click on the required question.
- 1 What does the term abortion mean?
- 2 What are the legal criteria that permit doctors to terminate a pregnancy in the UK?
- 3 How could we tell if there is a substantial risk that if the child were born it would suffer from such physical abnormalities as to be seriously handicapped - e.g. Down Syndrome?
- 3A What is Tay Sachs and should we test for it?
- 4 How prevalent is pregnancy termination?
- 5 Why do unwanted pregnancies occur?
- 6 I think I may be pregnant and I do not want to have a baby now. What should I do?
- 7 Should I terminate my pregnancy for social reasons?
- 8 How can my pregnancy be terminated?
- 9 What does a suction (surgical) termination of pregnancy involve?
- 10 What is a medical abortion?
- 11 What will happen to me if I have a medical abortion?
- 12 How do medical and surgical pregnancy termination compare?
- 13 What are the chances of medical termination failing?
- 14 What are the risks of pregnancy termination?
- 15 Why is there debate about the ethics of pregnancy termination?
- 16 Support Groups.
- 17 Where can I obtain more information?
Thank you for choosing to visit us.
This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT.
I do hope that you find the answers to your women's health questions in the patient information and medical advice provided.
